clonotypes that were undetectable in the blood but were present in independent joints or at several non-adjacent areas of the same joint. These joint restricted CD4+ clonotypes were generally small in size, were preferentially found in the IL-2R+ subpopulation, and persisted over time. A second type of clonogenic T cells in the synovial infiltrate had an unrestricted tissue distribution and was present at similar frequencies amongst activated and nonactivated T cells in the blood and affected joints. Ubiquitous clonotypes isolated from two different patients expressed sequence homologies of the TCR ( chain. Conclusions: Two types of expanded CD4+ clonotypes contribute to the T cell infiltrate in rheumatoid synovitis. Differences in the distribution pattern and in molecular features suggest that distinct mechanisms are supporting the clonal outgrowth of these two groups of clonotypes. Clonally expanded T cells restricted to the joint but present in several independent joints appear to respond to locally residing antigens. Clonogenic cells with an unrestricted distribution pattem and widespread activation in the blood and tissue may react to a different class of antigens which appear to be shared by multiple patients. T cell recognition in RA may be involved at several different levels and may be related to more than one pathomechanism.
INTRODUCTION
Rheumatoid arthritis (RA) is characterized by the accumulation of inflammatory cells in the synovial membrane resulting in irreversible damage of the joint architecture. The finding of a genetic association with MHC class II polymorphism has led to the model that the underlying pathologic event is the recognition of antigen by lesional T cells (1) (2) (3) (4) (5) (6) . Indirect evidence for a critical role of T cells has been provided by studies on the T cell receptor (TCR) gene segment usage in affected tissues (7, 8) . Originally, these studies were designed to identify a shared T cell response in the rheumatoid joint. Although such a common denominator in the synovial T cell response has not been reported, most investigators have been able to describe the presence of oligoclonal T cell populations in the synovial infiltrate (9) (10) (11) (12) (13) (14) (15) (16) . In general, the diversity of tissue infiltrating T cells was extensive (17, 18) . Individual proliferating T cell clones were small and did not lead to a major shift in the TCR BV gene segment repertoire (7, 15) . Each individual patient expressed a unique set of T cells proliferating in the synovium.
The finding of clonal T cell populations in the synovial inflammation is suggestive for the recognition of locally residing antigens. Specificity for a joint-specific antigen of the synovial T cell clonotypes would be supported by their local enrichment. Their limited size could be explained by the co-occurrence of antigen induced proliferation and antigen induced programmed cell death. The co-existing diversity of the global infiltrate may simply reflect that antigen specific T cells remain a minority in the lesions and only very few antigen specific T cells may be necessary to maintain the immune response. However, this model has been questioned because in situ T cell proliferation has not been observed and T cell activation products are infrequent in the synovium.
Alternative explanations for oligoclonal T cell populations in the synovial compartment include the selective enrichment of certain T cells based upon their ability to transmigrate into the tissue (19) (20) (21) . Enhanced capability for tissue migration has been associated with a memory phenotype of T cells, and indeed tissue infiltrating T cells in rheumatoid synovitis are almost exclusively composed of memory T cells. Thus, T cell clonotypes detected in the joint could simply reflect the advantage of preactivated T cells to home to the tissue. Oligoclonal T cell proliferation in the synovial tissue could also result from the release of tissue specific growth factors facilitating T cell growth. It has been proposed that resident cells in the joint can release IL-15, which then supports the proliferation and clonal expansion of IL-15 receptor (IL-1 5R) expressing T cells (22) .
Recent reports on the oligoclonality of circulating T cells in RA patients have added an additional level of complexity to the interpretation of dominant T cell populations in the synovial tissue. It is now accepted that CD8+ T cells are not as diverse as previously thought and regularly include expanded clonotypes (23) (24) (25) (26) . Clonal expansion of CD4+ T cells appears to be infrequent in normal individuals but is frequently encountered in RA patients (27, 28) .
Clonogenic CD4+ T cells in RA patients ex- press an unusual phenotype: they lack expression of the CD28 molecule (29, 30 if a minimum of 2 x 106 mononuclear cells could be recovered from the synovial tissue. Paired samples of synovial fluid and peripheral blood were ascertained in six patients. Thirteen of the 14 study patients were characterized for their HLA-DRB 1 alleles as described (32) and expressed at least one RA associated allele. Eight of the 14 patients produced rheumatoid factor (RF). Disease duration varied between 2 months and 36 years. Table 1 shows the demographic data of the study population.
Cell Purification For TCR analysis, synovial tissue was cut into small pieces and digested for 50 min at 37°C with 30 1:200 and further amplified under the same PCR conditions with the appropriate BV primer and a BJ specific primer (BJISI, 1S2, 2S1, 2S3, 2S5, and 2S7). A total of 30 amplification products was screened for each sample. The BV segments studied represent approximately 25% of the total repertoire (33) and included some of the previously implicated BV gene elements (7, 8) . The set of BJ primers covered approximately 70% of the BV-BJ paring combination frequencies for a given BV gene arrangement (34, 35) . The primer sequences have been recently described (28, 36) .
Amplified products were radioactively labeled and size-fractionated on a denaturing 5 % polyacrylamide gel. In this type of analysis, a Gaussian distribution of band intensities is characteristic for a polyclonal population and dominant bands are highly suggestive for clonal expansion (37) (38) (39) . Dominant bands shared between different RNA samples (e.g., activated and nonactivated T cells, peripheral and synovial T cells, samples from distinct joints, etc.) were excised, eluted, and then reamplified with a T7-BV primer and the BJ primer over 30 cycles under the same PCR conditions as outlined above. The amplified product was directly sequenced by reverse transcriptase mediated dideoxysequencing as described (40) . Mixing experiments of T cell clones with known sequences showed that the direct sequencing approach is sensitive enough to detect clonotypes which contribute more than 25% of the total PCR product (27) . tionated, and dominant bands were identified. Direct sequence analysis of eluted shared bands documented that the expression of a particular TCR specificity at independent sites of the inflammation was not uncommon. In all eight patients TCR sequences were found which had the following features: they had reached clonal dominance, they were transcribed at high frequencies in the joint but not in the blood, and they were expressed in several independent tissue samples ( Fig. 2) . In the eight patients, 60 joint restricted CD4+ clonotypes were detected. The TCR 1 chain sequences are listed in Table 2 . Within the window of the TCR repertoire tested, the frequency of such clonotypes ranged from 1 to 13 per patient. Joint-specific CD4+ T cells exhibited several distinguishing features. Many, but not all, of the joint-specific clonotypes displayed preference for the preactivated CD4+ T cell subset. Of the 60 clonotypes that fulfilled the criteria for jointspecificity, 34 were exclusively found among CD4+ IL-2R+ T cells ( Table 4 had rearranged a BV3 gene suggesting preferential recruitment of BV3+ T cells. The group of TCR sequences was too small to draw conclusions regarding the BJ gene expression which appeared to be diverse. However, comparison of the CDR3 region revealed a sequence homology between T cell clones derived from two distinct patients (Table 4 , bold letters). Both clones used a BV3 gene segment. The TCR sequence found in patient RMB included a FAL stretch in conjunction with a BJ2S 1 gene. Patient JAB carried a T cell clone with a FSL sequence combined with a BJ 1S I element.
RESULTS

Influence of Extra
Analysis of the clinical parameters of the patients studied showed a correlation of the occurrence of broadly distributed CD4+ clonotypes with the seronegative variant of RA. All 6 seronegative patients carried at least one clonotype present in the joint and in the blood. Conversely, only two out of eight RF+ patients had clonogenic CD4+ cells of that category. The difference in frequency was statistically significant at the p < 0.005 level. Disease duration was not a predictor for these clonogenic CD4+ populations. Ubiquitously distributed clonotypes were already detectable in patients with very early disease. Also, the HLA-DRB1 genotype did not predict whether a patient had widely distributed clonal CD4+ cells nor did antirheumatic therapy appear to influence the presence of such T cells.
DISCUSSION
Detailed examination of the synovial T cell infiltrate in this study revealed a series of observations, all of which strongly support the notion of an antigen dependent T cell response in the joint.
(1) Selected T cell specificities proliferate in situ and reach clonal dominance. (2) 85% of these clonotypes express IL-2R, indicative of recent triggering of the TCR. (3) T cells carrying identical TCR j3 chains have gained dominance in nonadjacent tissue fragments and in independent joints. Local enrichment, preactivation, and presence at different sites of the disease process have all been assumed to characterize the dynamics of disease-relevant and antigen-specific T cells. Short of demonstrating the antigen, these findings are highly suggestive for specific T cell responses occurring in the rheumatoid synovium.
The designation of joint-specific clones was based on the definition that sequencing of a dominant band in the size-fractionated PCR product from synovial T cells yielded an unequivocal TCR sequence while the corresponding bands derived from peripheral blood were polyclonal. The finding that joint-specific clones could be identified in different joints indeed suggests that they are present in the circulating T cell population. The direct sequencing approach of dominant bands only allows for the conclusion that the frequencies in the peripheral blood and synovial tissue are markedly different. To determine the actual frequencies of TCR 13 chain sequences in the peripheral blood compartment, we have established a liquid hybridization assay using CDR3 specific probes in a limiting dilution Antigen recognition in the affected tissue appears to involve a wide spectrum of T cells. In each BV family analyzed joint-specific CD4+ clonotypes were found. However, the size of each of the clonotypes remained small. Provided that the CD4+ clonotypes reported here indeed contact antigen residing in the joint and respond with expansion, they still remain a minority among a highly diverse T plain why the comparisons between BV gene segment frequencies in peripheral blood and synovial T cells have yielded conflicting data (7, 8, 11, 13, 40, 41) . Our results are in line with the frequencies found in local antigen-specific responses and in other chronic inflammatory diseases (6, (42) (43) (44) (45) . Surprisingly, preactivation of circulating T cells as judged by the expression of the IL-2R was The ubiquitous clonotypes are most likely identical to the clonally expanded CD4+ T cells recently described in the blood of RA patients (27, 28) . These CD4+ T cell clones were autoreactive and expressed an usual phenotype in that they lacked the expression of CD28 (29) . Systematic analysis of CD4+ CD28 T cells in a cohort of RA patients has led to identification of TCR ,B chains with almost identical sequences expressed in distinct patients (30) . As shown in Table 4 (23, 24) . These cells lack the expression of CD28 and have a limited TCR (3 chain diversity with a preferential usage of AV12 and BV3 and sharing of junctional sequences (23, 46 (27, 47) .
In patients who were monitored over time, no change in the distribution pattern could be documented. CD4+ clones restricted to the joint remained joint-specific (Table 3) . Also, among the widespread T cell clones, TCR ,B chains with sequence homologies were readily identified when different patients were compared (30; 
